Exact Mass: 259.1909242

Exact Mass Matches: 259.1909242

Found 78 metabolites which its exact mass value is equals to given mass value 259.1909242, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Isoleucyl-Lysine

6-Amino-2-[(2-amino-1-hydroxy-3-methylpentylidene)amino]hexanoate

C12H25N3O3 (259.189582)


Isoleucyl-Lysine is a dipeptide composed of isoleucine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Lysylisoleucine

(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanoic acid

C12H25N3O3 (259.189582)


Lysylisoleucine is a dipeptide composed of lysine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Leucyl-Lysine

6-Amino-2-[(2-amino-1-hydroxy-4-methylpentylidene)amino]hexanoate

C12H25N3O3 (259.189582)


Leucyl-Lysine is a dipeptide composed of leucine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Lysylleucine

(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanoic acid

C12H25N3O3 (259.189582)


Lysylleucine is a dipeptide composed of lysine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

(-)-Vesamicol

2-(4-phenylpiperidin-1-yl)cyclohexan-1-ol

C17H25NO (259.193604)


   

1-(1-Phenylcyclohexyl)-4-hydroxypiperidine

1-(1-Phenylcyclohexyl)-4-hydroxypiperidine

C17H25NO (259.193604)


   

4-Phenyl-4-piperidinocyclohexanol

4-Phenyl-4-piperidinocyclohexanol, (trans)-isomer

C17H25NO (259.193604)


   

Eperisone

1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one

C17H25NO (259.193604)


M - Musculo-skeletal system > M03 - Muscle relaxants > M03B - Muscle relaxants, centrally acting agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

   

12-pyridin-2-yldodeca-6,8-dien-2-ol

12-pyridin-2-yldodeca-6,8-dien-2-ol

C17H25NO (259.193604)


   

1-(1-Phenylcyclohexyl)-4-hydroxypiperidine

1-(1-Phenylcyclohexyl)-4-hydroxypiperidine

C17H25NO (259.193604)


   

4-Phenyl-4-piperidinocyclohexanol

4-Phenyl-4-piperidinocyclohexanol

C17H25NO (259.193604)


   

alpha-pyrrolidinoheptaphenone

alpha-pyrrolidinoheptaphenone

C17H25NO (259.193604)


   

vesamicol

vesamicol

C17H25NO (259.193604)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents (-)-Vesamicol (AH5183) is an inhibitor of acetylcholine transport into synaptic vesicles, with the IC50 of 75 nM[1]. (-)-Vesamicol can be used for release and recycling of synaptic vesicles study[1]. (-)-Vesamicol (AH5183) is an inhibitor of acetylcholine transport into synaptic vesicles, with the IC50 of 75 nM[1]. (-)-Vesamicol can be used for release and recycling of synaptic vesicles study[1].

   

undeca-2Z-en-8,10-diynoic acid 2-methylbutylamide

undeca-2Z-en-8,10-diynoic acid 2-methylbutylamide

C17H25NO (259.193604)


   
   

Haminol 3|Haminol-3

Haminol 3|Haminol-3

C17H25NO (259.193604)


   

(-)-histrionicotoxin 259A|(?)-histrionicotoxin 259A|histrionicotoxin 259

(-)-histrionicotoxin 259A|(?)-histrionicotoxin 259A|histrionicotoxin 259

C17H25NO (259.193604)


   

Dhydrodarlingianine|Dihydrodarlingianin

Dhydrodarlingianine|Dihydrodarlingianin

C17H25NO (259.193604)


   

(7Z)-N-(isobutyl)-7-tridecene-10,12-diynamide

(7Z)-N-(isobutyl)-7-tridecene-10,12-diynamide

C17H25NO (259.193604)


   
   
   
   
   

(2S,6R,7S,8S)-2-allyl-7-((E)-but-1-en-3-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2S,6R,7S,8S)-2-allyl-7-((E)-but-1-en-3-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

C17H25NO (259.193604)


   

Ile-lys

2-(2,6-diaminohexanamido)-3-methylpentanoic acid

C12H25N3O3 (259.189582)


   

Leu-lys

2-(2,6-diaminohexanamido)-4-methylpentanoic acid

C12H25N3O3 (259.189582)


A dipeptide composed of L-leucine and L-lysine joined by a peptide linkage.

   

Lys-ile

6-amino-2-(2-amino-3-methylpentanamido)hexanoic acid

C12H25N3O3 (259.189582)


A dipeptide formed from L-lysine and L-isoleucine residues.

   

Lys-leu

6-amino-2-(2-amino-4-methylpentanamido)hexanoic acid

C12H25N3O3 (259.189582)


A dipeptide formed from L-lysine and L-leucine residues.

   

4-Methyl-α-pyrrolidinohexanophenone

4-Methyl-α-pyrrolidinohexanophenone

C17H25NO (259.193604)


   

NA 17:5

N-isobutyl-7Z-tridecene-10,12-diynamide

C17H25NO (259.193604)


   

4-DECYLOXY-BENZONITRILE

4-DECYLOXY-BENZONITRILE

C17H25NO (259.193604)


   

4-(PENTAMETHYLBENZOYL)PIPERIDINE

4-(PENTAMETHYLBENZOYL)PIPERIDINE

C17H25NO (259.193604)


   

(+/-)-1-AMINO-3-N-(4-BOC-PIPERAZINYL)-2-PROPANOL

(+/-)-1-AMINO-3-N-(4-BOC-PIPERAZINYL)-2-PROPANOL

C12H25N3O3 (259.189582)


   

1-[6-(TERT-BUTYL)-1,1-DIMETHYL-2,3-DIHYDRO-1H-INDEN-4-YL]ETHAN-1-ONE OXIME

1-[6-(TERT-BUTYL)-1,1-DIMETHYL-2,3-DIHYDRO-1H-INDEN-4-YL]ETHAN-1-ONE OXIME

C17H25NO (259.193604)


   

2-(pyrrolidin-1-yl)-1-p-tolylhexan-1-one

2-(pyrrolidin-1-yl)-1-p-tolylhexan-1-one

C17H25NO (259.193604)


   
   

2-(4-phenylpiperidin-1-yl)cyclohexan-1-ol

2-(4-phenylpiperidin-1-yl)cyclohexan-1-ol

C17H25NO (259.193604)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents

   

1-Phenyl-2-(pyrrolidin-1-yl)heptan-1-one

1-Phenyl-2-(pyrrolidin-1-yl)heptan-1-one

C17H25NO (259.193604)


   

3,4-Dimethyl-alpha-pyrrolizinovalerophenone

3,4-Dimethyl-alpha-pyrrolizinovalerophenone

C17H25NO (259.193604)


   
   
   

Eperisone

Eperisone

C17H25NO (259.193604)


M - Musculo-skeletal system > M03 - Muscle relaxants > M03B - Muscle relaxants, centrally acting agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

   

L-Isoleucyl-L-lysine

L-Isoleucyl-L-lysine

C12H25N3O3 (259.189582)


   
   

1-[4-(2-Prop-2-enylphenoxy)butyl]pyrrolidine

1-[4-(2-Prop-2-enylphenoxy)butyl]pyrrolidine

C17H25NO (259.193604)


   

1-[(2S,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

1-[(2S,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

C12H25N3O3 (259.189582)


   

1-[(2R,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)oxan-3-yl]-3-propan-2-ylurea

1-[(2R,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)oxan-3-yl]-3-propan-2-ylurea

C12H25N3O3 (259.189582)


   

1-[(2S,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)oxan-3-yl]-3-propan-2-ylurea

1-[(2S,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)oxan-3-yl]-3-propan-2-ylurea

C12H25N3O3 (259.189582)


   

(2R)-2-hydroperoxytetradecanoate

(2R)-2-hydroperoxytetradecanoate

C14H27O4- (259.1909242)


   

1-[(2R,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

1-[(2R,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

C12H25N3O3 (259.189582)


   

1-[(2S,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

1-[(2S,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

C12H25N3O3 (259.189582)


   

1-[(2R,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

1-[(2R,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

C12H25N3O3 (259.189582)


   

1-[(2R,3S,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

1-[(2R,3S,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

C12H25N3O3 (259.189582)


   

7,11-Dihydroxytetradecanoate

7,11-Dihydroxytetradecanoate

C14H27O4- (259.1909242)


   

5-[4-(3-Aminopropylamino)butylamino]-5-oxopentanoic acid

5-[4-(3-Aminopropylamino)butylamino]-5-oxopentanoic acid

C12H25N3O3 (259.189582)


   

5-[3-(4-Aminobutylamino)propylamino]-5-oxopentanoic acid

5-[3-(4-Aminobutylamino)propylamino]-5-oxopentanoic acid

C12H25N3O3 (259.189582)


   

N-(2-Butenyl)-N-(2-methyl-1-phenylpropyl)propanamide

N-(2-Butenyl)-N-(2-methyl-1-phenylpropyl)propanamide

C17H25NO (259.193604)


   
   
   

n-(2-methylbutyl)dodec-2-en-8,10-diynimidic acid

n-(2-methylbutyl)dodec-2-en-8,10-diynimidic acid

C17H25NO (259.193604)


   

1-(1-methylpyrrolidin-2-yl)-6-phenylhex-5-en-2-ol

1-(1-methylpyrrolidin-2-yl)-6-phenylhex-5-en-2-ol

C17H25NO (259.193604)


   

(2e)-n-[(2s)-2-methylbutyl]dodec-2-en-8,10-diynimidic acid

(2e)-n-[(2s)-2-methylbutyl]dodec-2-en-8,10-diynimidic acid

C17H25NO (259.193604)


   

(2s,6r,7s,8s)-7-[(1z)-but-1-en-3-yn-1-yl]-2-(prop-2-en-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2s,6r,7s,8s)-7-[(1z)-but-1-en-3-yn-1-yl]-2-(prop-2-en-1-yl)-1-azaspiro[5.5]undecan-8-ol

C17H25NO (259.193604)


   

(2s,4e,6e)-12-(pyridin-3-yl)dodeca-4,6-dien-2-ol

(2s,4e,6e)-12-(pyridin-3-yl)dodeca-4,6-dien-2-ol

C17H25NO (259.193604)


   

(2r,5e)-1-[(2r)-1-methylpyrrolidin-2-yl]-6-phenylhex-5-en-2-ol

(2r,5e)-1-[(2r)-1-methylpyrrolidin-2-yl]-6-phenylhex-5-en-2-ol

C17H25NO (259.193604)


   

(7z)-n-(2-methylpropyl)tridec-7-en-10,12-diynimidic acid

(7z)-n-(2-methylpropyl)tridec-7-en-10,12-diynimidic acid

C17H25NO (259.193604)


   

(2r,6e,8e)-12-(pyridin-2-yl)dodeca-6,8-dien-2-ol

(2r,6e,8e)-12-(pyridin-2-yl)dodeca-6,8-dien-2-ol

C17H25NO (259.193604)


   

n-(2-methylpropyl)tridec-7-en-10,12-diynimidic acid

n-(2-methylpropyl)tridec-7-en-10,12-diynimidic acid

C17H25NO (259.193604)


   

7-[(1e)-but-1-en-3-yn-1-yl]-2-(prop-2-en-1-yl)-1-azaspiro[5.5]undecan-8-ol

7-[(1e)-but-1-en-3-yn-1-yl]-2-(prop-2-en-1-yl)-1-azaspiro[5.5]undecan-8-ol

C17H25NO (259.193604)


   

(2z)-n-[(2s)-2-methylbutyl]dodec-2-en-8,10-diynimidic acid

(2z)-n-[(2s)-2-methylbutyl]dodec-2-en-8,10-diynimidic acid

C17H25NO (259.193604)


   

(2e)-n-(2-methylbutyl)dodec-2-en-8,10-diynimidic acid

(2e)-n-(2-methylbutyl)dodec-2-en-8,10-diynimidic acid

C17H25NO (259.193604)


   

(5z)-n-(2-methylpropyl)tridec-5-en-10,12-diynimidic acid

(5z)-n-(2-methylpropyl)tridec-5-en-10,12-diynimidic acid

C17H25NO (259.193604)


   

(1z)-2-[(1s)-1-(c-hydroxycarbonimidoyl)-2-methoxyethyl]-1-octyldiazen-1-ium-1-olate

(1z)-2-[(1s)-1-(c-hydroxycarbonimidoyl)-2-methoxyethyl]-1-octyldiazen-1-ium-1-olate

C12H25N3O3 (259.189582)


   

12-(pyridin-2-yl)dodeca-6,8-dien-2-ol

12-(pyridin-2-yl)dodeca-6,8-dien-2-ol

C17H25NO (259.193604)


   

(2e,4e,8z,10e,12e)-n-isopropyltetradeca-2,4,8,10,12-pentaenimidic acid

(2e,4e,8z,10e,12e)-n-isopropyltetradeca-2,4,8,10,12-pentaenimidic acid

C17H25NO (259.193604)


   

[1-(c-hydroxycarbonimidoyl)-2-methoxyethyl](octyl-oxo-λ⁵-azanylidene)amine

[1-(c-hydroxycarbonimidoyl)-2-methoxyethyl](octyl-oxo-λ⁵-azanylidene)amine

C12H25N3O3 (259.189582)


   

12-(pyridin-3-yl)dodeca-4,6-dien-2-ol

12-(pyridin-3-yl)dodeca-4,6-dien-2-ol

C17H25NO (259.193604)


   

(6e,8e)-12-(pyridin-2-yl)dodeca-6,8-dien-2-ol

(6e,8e)-12-(pyridin-2-yl)dodeca-6,8-dien-2-ol

C17H25NO (259.193604)